Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 4 (April)

1. The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner.
   Cancer Res, 68(7): 2312-20. [Abstract] [Full-text]
2. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
   Carcinogenesis, 29(4): 849-57. [Abstract] [Full-text]
3. Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3.
   Carcinogenesis, 29(4): 790-6. [Abstract] [Full-text]
4. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.
   Cancer Sci, 99(5): 879-87. [Abstract] [Full-text]
5. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
   Int J Cancer, 122(11): 2462-70. [Abstract] [Full-text]
6. Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
   Int J Cancer, 122(11): 2491-7. [Abstract] [Full-text]
7. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
   J Surg Res, 146(1): 16-23. [Abstract] [Full-text]
8. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy.
   Nat Med, 14(4): 454-8. [Abstract] [Full-text]
9. Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum.
   Semin Oncol, 35(2): 183-91. [Abstract] [Full-text]
10. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
    Gastroenterology, 134(4): 998-1006. [Abstract] [Full-text]
11. p53 regulates FAK expression in human tumor cells.
    Mol Carcinog, 47(5): 373-82. [Abstract] [Full-text]
12. Human APC sequesters beta-catenin even in the absence of GSK-3beta in a Drosophila model.
    Oncogene, 27(17): 2488-93. [Abstract] [Full-text]
13. Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC).
    Mol Carcinog, 47(5): 321-5. [Abstract] [Full-text]
14. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Expert Rev Anticancer Ther, 8(4): 595-604. [Abstract] [Full-text]
15. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
    Expert Rev Anticancer Ther, 8(4): 547-51. [Abstract] [Full-text]
16. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.
    Gut, 57(5): 613-22. [Abstract] [Full-text]
17. Guidelines for the clinical management of familial adenomatous polyposis (FAP).
    Gut, 57(5): 704-13. [Abstract] [Full-text]
18. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.
    Gut, 57(5): 623-7. [Abstract] [Full-text]
19. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Cancer Lett, 263(2): 267-79. [Abstract] [Full-text]
20. Not all acute lower back pain is benign--paravertebral abscess and colonic cancer.
    Am J Emerg Med, 26(4): 513.e3-4. [Abstract] [Full-text]
21. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Biochem Biophys Res Commun, 370(1): 145-8. [Abstract] [Full-text]
22. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models.
    Clin Cancer Res, 14(8): 2502-10. [Abstract] [Full-text]
23. Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model.
    Clin Cancer Res, 14(8): 2253-62. [Abstract] [Full-text]
24. Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.
    Immunology, 124(1): 33-41. [Abstract] [Full-text]
25. Clinical utility of type 1 growth factor receptor expression in colon cancer.
    Am J Surg, 195(5): 604-10. [Abstract] [Full-text]
26. Cellular expression patterns of genes upregulated in murine and human colonic neoplasms.
    J Histochem Cytochem, 56(5): 433-41. [Abstract] [Full-text]
27. Reduction of Calponin h1 expression in human colon cancer blood vessels.
    Eur J Surg Oncol, 34(5): 531-7. [Abstract] [Full-text]
28. Effect of modified Davidson's fixative on examined number of lymph nodes and TNM-stage in colon carcinoma.
    Eur J Surg Oncol, 34(5): 525-30. [Abstract] [Full-text]
29. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers.
    Ann Surg, 247(4): 650-8. [Abstract] [Full-text]
30. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon.
    Nat Genet, 40(5): 600-8. [Abstract] [Full-text]
31. Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model.
    Oncology, 73(3): 252-60. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.